No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

RSIP Vision Launches a New Knee Segmentation and Landmark Detection from X-ray Module

Editor: What To Know

  • RSIP Vision, a global supplier of medical artificial intelligence (AI), computer vision, and image processing technology, has announced the release of an innovative new AI bone segmentation and landmark detection module that will dramatically improve pre-operative planning, intraoperative guidance, and post-operative patient experience in knee replacement surgery.
  • Implants can be positioned in several ways, and accurately fitting this implant is crucial to the success of the operation and future health and quality of life outcomes for the patients.
  • Our expertise in deep learning, image analysis and computer vision, combined with years of experience in the medical domain, has enabled us to develop a line of AI modules tailored to the orthopedics field.

RSIP Vision, a global supplier of medical artificial intelligence (AI), computer vision, and image processing technology, has announced the release of an innovative new AI bone segmentation and landmark detection module that will dramatically improve pre-operative planning, intraoperative guidance, and post-operative patient experience in knee replacement surgery.

By leveraging the power of RSIP Vision’s novel AI module, surgeons and radiologists can automatically collect – from regular X-ray images only – the accurate measurements they want. This provides them with the critical data they need to design the best possible implants for patients. This crucial planning process is now simplified, making it faster and more precise, allowing the surgeon to plan the implant positioning with perfect accuracy. This module will serve a much wider segment than the existing CT module since most medical centers use X-ray for these procedures on a daily basis.

Knee replacement surgery is one of the most common procedures in orthopedics, with more than 790,000 surgeries carried out each year in the US alone. According to the American Academy of Orthopaedic Surgeons (AAOS), this figure is expected to grow to 1.28m by 2030. It can be a difficult procedure with a painful recovery and a long rehabilitation period.

In total knee replacement surgery, also known as total knee arthroplasty (TKA), the severely damaged bone is replaced with an implant. Implants can be positioned in several ways, and accurately fitting this implant is crucial to the success of the operation and future health and quality of life outcomes for the patients.

X-ray images are commonly used to get a good understanding of the bone, including its size and location. Numerical measurements that define resection lines, implant size, and final bone position are vital to determine the optimal configuration of the implant location. This process relies heavily on the accurate detection of anatomical landmarks and segmentation of each bone, to provide important data such as angles and surface measurements.

However, X-ray images can be challenging for manual interpretation and measurements. In recent years, AI and deep learning introduced significant advances to the medical field; this enables RSIP Vision to develop the new module which accurately detects and maps the anatomical structure of the bones from X-ray only.

RSIP Vision founder and CEO, Ron Soferman, said: “This novel technology marks another milestone in RSIP Vision’s revolutionary work to improve the lives of millions of people who undergo knee surgery every year. Our expertise in deep learning, image analysis and computer vision, combined with years of experience in the medical domain, has enabled us to develop a line of AI modules tailored to the orthopedics field.

By reducing the planning and surgery time and solving the main challenges of orthopedic procedures, RSIP Vision’s innovative AI bone segmentation and landmark detection X-ray module provides a robust solution: it enhances the clinical capabilities of our clients, the large orthopedics vendors, allowing them to secure an improved patient outcome, a higher surgical success rate, and shorter recovery time.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy